Table 3.
Benefits | Mechanism |
---|---|
Solute clearance | • B2-microglobulin • protein bound solutes |
Volume control | • Lower ultrafiltration volumes in each hemodialysis session • Less intradialytic hypotension • Less myocardial stunning • reduction in cardiovascular mortality |
Inflammatory reduction | • C-reactive protein and interleukin-6 |
Anemia management | • Less anemia with less use of epoetin alpha |
Nutritional improvement | • Better overall nutritional status • Better control of serum phosphorus. |
Quality of life and survival | • Better quality of life |